Osteopore gains China product approval
Bone reconstruction technology company Osteopore has broken into the China market with its regenerative bone scaffold implants used to speed healing in craniofacial surgery. The Singapore and Australian company has won approval from the Hong Kong regulatory authority, allowing it to market its bioresorbable polymer implants in the Greater Bay Area, a region covering 11…